The FDA has approved Novartis‘ Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) tablets, a combination product containing a calcium channel blocker, an ...

With Teva being the first to file, the company will enjoy 180 days of marketing exclusivity. As per IMS data, Exforge HCT tablets recorded annual sales of approximately $158 million in the U.S. as of ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Exforge HCT contains the active ingredients Amlodipine Besilate, ...

EAST HANOVER, N.J., Aug. 4 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT(R) (valsartan and hydrochlorothiazide) and Exforge ...

The FDA has approved Novartis’ Diovan HCT (valsartan/hydrochlorothiazide tablets) and Exforge (amlodipine/valsartan tablets) as first-line therapies for hypertension in patients likely to need ...

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the launch of the generic equivalent to Exforge HCT® (Amlodipine, Valsartan, Hydrochlorothiazide) Tablets in the ...

Novartis has received a major boost in the USA after regulators there gave their backing to two of the Swiss major’s combination high blood-pressure drugs which can now be used as first-line ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. AMLODIPINE/VALSARTAN/HCT NOVARTIS contains the active ingredients ...

Teva was first to file for the generic, according to the company. Exforge HCT tablets, which are marketed by Novartis, had annual sales in the United States of approximately $158 million as of ...

HANOVER, NJ — More than five-million bottles of antihypertensives, statins, and other drugs made by Novartis may have been contaminated by a chemical used in their packaging, the company has confirmed ...

Teva Pharmaceutical Industries Limited ( TEVA) has launched its generic version of Novartis' ( NVS) Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) tablets in the U.S. Exforge HCT is approved ...

Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies[1] Up to 80% of patients may need multiple medications to help them reach blood ...